Paper39021815
Herbal Products as Complementary or Alternative Medicine for the Management of Hyperglycemia and Dyslipidemia in Patients with Type 2 Diabetes: Current Evidence Based on Findings of Interventional Studies.
Farhadnejad H and 9 others. J Nutr Metab, 2024. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Herbal Products as Complementary or Alternative Medicine for the Management of Hyperglycemia and Dyslipidemia in Patients with Type 2 Diabetes: Current Evidence Based on Findings of Interventional Studies. Papers, record 39021815. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39021815
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Herbal Products as Complementary or Alternative Medicine for the Management of Hyperglycemia and Dyslipidemia in Patients with Type 2 Diabetes: Current Evidence Based on Findings of Interventional Studies.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References142
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33520813 | Glycemic control and associated factors among Iranian population with type 2 diabetes mellitus: a cross-sectional study. | J Diabetes Metab Disord | 2020 | https://conductscience.org/library/papers/33520813 | PubMed |
| 2 | 35754684 | The Effect of Curcumin on Lipid Profile and Glycemic Status of Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. | Evid Based Complement Alternat Med | 2022 | https://conductscience.org/library/papers/35754684 | PubMed |
| 3 | 680944 | Further studies on pharmacology of berberine. | Indian J Physiol Pharmacol | 1978 | https://conductscience.org/library/papers/680944 | PubMed |
| 4 | 29661513 | Cinnamon: A systematic review of adverse events. | Clin Nutr | 2019 | https://conductscience.org/library/papers/29661513 | PubMed |
| 5 | 28106738 | 6-Paradol and 6-Shogaol, the Pungent Compounds of Ginger, Promote Glucose Utilization in Adipocytes and Myotubes, and 6-Paradol Reduces Blood Glucose in High-Fat Diet-Fed Mice. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28106738 | PubMed |
| 6 | 22058071 | Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. | Mol Nutr Food Res | 2011 | https://conductscience.org/library/papers/22058071 | PubMed |
| 7 | 22948795 | Effect of crocin on the insulin resistance and lipid profile of streptozotocin-induced diabetic rats. | Phytother Res | 2013 | https://conductscience.org/library/papers/22948795 | PubMed |
| 8 | 37748368 | Effects of curcumin/turmeric supplementation on glycemic indices in adults: A grade-assessed systematic review and dose-response meta-analysis of randomized controlled trials. | Diabetes Metab Syndr | 2023 | https://conductscience.org/library/papers/37748368 | PubMed |
| 9 | 33739219 | The beneficial effects of cinnamon among patients with metabolic diseases: A systematic review and dose-response meta-analysis of randomized-controlled trials. | Crit Rev Food Sci Nutr | 2022 | https://conductscience.org/library/papers/33739219 | PubMed |
| 10 | 27861946 | Saffron: a promising natural medicine in the treatment of metabolic syndrome. | J Sci Food Agric | 2017 | https://conductscience.org/library/papers/27861946 | PubMed |
| 11 | 8508473 | Cholesterol biosynthesis inhibitory component from Zingiber officinale Roscoe. | Chem Pharm Bull (Tokyo) | 1993 | https://conductscience.org/library/papers/8508473 | PubMed |
| 12 | 31935866 | Ginger on Human Health: A Comprehensive Systematic Review of 109 Randomized Controlled Trials. | Nutrients | 2020 | https://conductscience.org/library/papers/31935866 | PubMed |
| 13 | 33041781 | Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33041781 | PubMed |
| 14 | 32227501 | The effect of dried Ziziphus vulgaris on glycemic control, lipid profile, Apo-proteins and hs-CRP in patients with type 2 diabetes mellitus: A randomized controlled clinical trial. | J Food Biochem | 2021 | https://conductscience.org/library/papers/32227501 | PubMed |
| 15 | 27440832 | Glucose Control and Vascular Outcomes in Type 2 Diabetes: Is the Picture Clear? | Diabetes Care | 2016 | https://conductscience.org/library/papers/27440832 | PubMed |
| 16 | 16424788 | Crocetin attenuates atherosclerosis in hyperlipidemic rabbits through inhibition of LDL oxidation. | J Cardiovasc Pharmacol | 2006 | https://conductscience.org/library/papers/16424788 | PubMed |
| 17 | 29650089 | Complementary and Alternative Medicine for Diabetes. | Can J Diabetes | 2018 | https://conductscience.org/library/papers/29650089 | PubMed |
| 18 | 10641152 | Anti-oxidant effects of cinnamon (Cinnamomum verum) bark and greater cardamom (Amomum subulatum) seeds in rats fed high fat diet. | Indian J Exp Biol | 1999 | https://conductscience.org/library/papers/10641152 | PubMed |
| 19 | 31991895 | Steamed Ginger May Enhance Insulin Secretion through KATP Channel Closure in Pancreatic β-Cells Potentially by Increasing 1-Dehydro-6-Gingerdione Content. | Nutrients | 2020 | https://conductscience.org/library/papers/31991895 | PubMed |
| 20 | 24936248 | Functional foods-based diet as a novel dietary approach for management of type 2 diabetes and its complications: A review. | World J Diabetes | 2014 | https://conductscience.org/library/papers/24936248 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42275391 | Production of anti-inflammatory and antidiabetic oligosaccharides from okra mucilage through one-step microbial fermentation. | PLoS One | 2026 | https://conductscience.org/library/papers/42275391 | PubMed |
| 41516183 | Metabolic and Antioxidant Modulation by Artemisia indica Willd. Aqueous Extract in Glucose and Cholesterol Dysregulation. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516183 | PubMed |
| 41462455 | Effect of digital interventions on adherence to the management of type 1 diabetes mellitus patients: a systematic review. | BMC Endocr Disord | 2025 | https://conductscience.org/library/papers/41462455 | PubMed |
| 41261111 | Dosage exploration of the effects of honey and its derivatives on cardiometabolic outcomes: an overview of systematic reviews and GRADE-assessed updated meta-analysis. | Nutr Diabetes | 2025 | https://conductscience.org/library/papers/41261111 | PubMed |
| 40872533 | Lepisanthes alata Attenuates Carrageenan-Induced Inflammation and Pain in Rats: A Phytochemical-Based Approach. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40872533 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39021815
GET https://conductscience.org/api/papers/v1/39021815/references?page=2